Interdisciplinary Research on Artificial Intelligence and Longevity Medicine: Global Landscape, Collaboration Networks, and Frontier Trends (2010–2025)

Huang Xinyan, Tan Jianshu, Cao Shuqin, Di Longkang, Kang Lunwei, Zhu Zhuoli, Liao Ga

Abstract

Objective

With the expansion of theories concerning aging and the rapid evolution of artificial intelligence (AI) methodologies, the integration of AI and longevity medicine has emerged as a critical pathway for extending human healthspan. This study is aimed at a systematic characterization of the research landscape, collaboration networks, and frontier trends in this interdisciplinary field, so as to inform clinical translation and the development of the health management industry.

Methods

The Web of Science Core Collection, including Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI), was used as the data source. English-language publications in the interdisciplinary field of AI and longevity medicine between 2010 and 2025 were systematically retrieved, and 4170 valid records were included for a joint analysis using Bibliometrix and CiteSpace 7.0.

Results

Annual publication output showed exponential growth. The global research landscape exhibited a China–US dual-core and a multipolar pattern, with institutional collaborations clustering into 3 major networks spanning Asia–Europe, the United States, and Continental Europe. Research topics were clustered into five major themes—the core concepts of aging and multimorbidity, AI-driven body composition and musculoskeletal assessment, deep-learning-based evaluation of brain aging through neuroimaging, wearable sensing and mobile health, and digital phenotyping and mental health. Marked differences in research priorities were observed among the three leading contributors, including China, the United States, and the United Kingdom. China demonstrated broad research coverage and clinically oriented multi-track development, the United States led in methodological innovation and digital phenotyping, and the United Kingdom concentrated on brain age research.

Conclusions

This study systematically delineates the research landscape, collaboration networks, and frontier trajectories in the interdisciplinary field of AI and longevity medicine, providing data-driven evidence and decision-making support for advancing clinical translation and the development of the health management industry in this field.

 

 Keywords: Artificial intelligence, Longevity medicine, Geroscience, Aging biomarkers, Brain age, Digital phenotyping, CiteSpace


Full Text:

PDF


References


López-otín C, Blasco M A, Partridge L, et al. The hallmarks of aging[J]. Cell, 2013, 153(6): 1194-1217. DOI: 10.1016/j.cell.2013.05.039.

López-otín C, Blasco M A, Partridge L, et al. Hallmarks of aging: An expanding universe[J]. Cell, 2023, 186(2): 243-278. DOI: 10.1016/j.cell. 2022.11.001.

Kennedy B K, Berger S L, Brunet A, et al. Geroscience: linking aging to chronic disease[J]. Cell, 2014, 159(4): 709-713. DOI: 10.1016/j.cell.2014.10.039. Bischof E, Scheibye-knudsen M, Siow R, et al. Longevity medicine: upskilling the physicians of tomorrow[J/OL]. Lancet Healthy Longev, 2021, 2(4): e187-e188. https://doi.org/0.1016/S2666-7568(21)00024-6.

Kroemer G, Meij H J, Maier A B. Geromedicine: a new journal for the clinical application of geroscience[J]. Geromedicine, 2025, 1(1): GER_202501. DOI: 10.70401/geromedicine.2025.0001.

Kroemer G, Maier A B, Cuervo A M, et al. From geroscience to precision geromedicine: understanding and managing aging[J]. Cell, 2025, 188(8): 2043-2062. DOI: 10.1016/j.cell.2025.03.011.

De Lima camillo L P, Lapierre L R, Singh R. A pan-tissue DNA-methylation epigenetic clock based on deep learning[J]. NPJ Aging, 2022, 8(1): 4. DOI: 10.1038/s41514-022-00085-y.

Teschendorff A E, Horvath S. Epigenetic ageing clocks: statistical methods and emerging computational challenges[J]. Nat Rev Genet, 2025, 26(5): 350-368. DOI: 10.1038/s41576-024-00807-w.

Cole J H, Franke K. Predicting age using neuroimaging: innovative brain ageing biomarkers[J]. Trends Neurosci, 2017, 40(12): 681-690. DOI: 10. 1016/j.tins.2017.10.001.

Zhu Z, Shi D, Guankai P, et al. Retinal age gap as a predictive biomarker for mortality risk[J]. Br J Ophthalmol, 2023, 107(4): 547-554. DOI: 10. 1136/bjophthalmol-2021-319807.

Chen Y, Klein S L, Garibaldi B T, et al. Aging in COVID-19: vulnerability, immunity and intervention[J]. Ageing Res Rev, 2021, 65: 101205. DOI: 10. 1016/j.arr.2020.101205.

Thirunavukarasu A J, Ting D S J, Elangovan K, et al. Large language models in medicine[J]. Nat Med, 2023, 29(8): 1930-1940. DOI: 10.1038/s41591-023-02448-8.

Topol E J. High-performance medicine: the convergence of human and artificial intelligence[J]. Nat Med, 2019, 25(1): 44-56. DOI: 10.1038/s41591-018-0300-7.

Ferrucci L. The Baltimore Longitudinal Study of Aging (BLSA): a 50-year-long journey and plans for the future[J]. J Gerontol A Biol Sci Med Sci, 2008, 63(12): 1416-1419. DOI: 10.1093/gerona/63.12.1416.

National Health Commission, National Development and Reform Commission, Ministry of Industry and Information Technology. Implementation opinions on promoting and regulating the development of "AI + Healthcare" applications: No. 30[2025][EB/OL]. (2025-10-20)[2026-03-31]. https://www.gov.cn/zhengce/zhengceku/202511/content_7047018.htm.

Cao H, Song Z, Duggan M R, et al. MRI-based multi-organ clocks for healthy aging and disease assessment[J]. Nat Med, 2026, 32(1): 82-92. DOI: 10.1038/s41591-025-03999-8.

Shim J, Fleisch E, Barata F. Circadian rhythm analysis using wearable-based accelerometry as a digital biomarker of aging and healthspan[J]. npj Digit Med, 2024, 7(1): 146. DOI: 10.1038/s41746-024-01111-x.

National Bureau of Statistics of China. Statistical communiqué of the People's Republic of China on the 2024 national economic and social development[EB/OL] (2025-02-28)[2026-03-31]. https://www.stats.gov. cn/sj/zxfb/202502/t20250228_1958817.html.

Liu J, Ding Q Q, Zhou B Y, et al. Chinese expert consensus on the diagnosis and treatment of sarcopenia in the elderly (2021)[J]. Chin J Geriatr, 2021, 40(8): 943-952.

Meng S, He X, Fu X, et al. The prevalence of sarcopenia and risk factors in the older adult in China: a systematic review and meta-analysis[J]. Front Public Health, 2024, 12: 1415398. DOI: 10.3389/fpubh.2024.1415398.

Cheng X, Zhao K, Zha X, et al. Opportunistic screening using low-dose CT and the prevalence of osteoporosis in China: a nationwide, multicenter study[J]. J Bone Miner Res, 2021, 36(3): 427-435.

Gu S, Wang L, Han R, et al. Detection of sarcopenia using deep learning-based artificial intelligence body part measure system (AIBMS)[J]. Front Physiol, 2023, 14: 1092352. DOI: 10.3389/fphys.2023.1092352.

Tan X, Liu X, Shao H. Healthy China 2030: a vision for health care[J]. Value Health Reg Issues, 2017, 12: 112-114. DOI: 10.1016/j.vhri.2017.04.001.

National Health Commission, Ministry of Education, Ministry of Science and Technology, et al. The "14th Five-Year Plan" for healthy aging: No. 4 [2022][EB/OL]. (2022-02-07)[2026-03-31]. https://www.gov.cn/zhengce/zhengceku/2022-03/01/content_5676342.htm.

Cole J H, Poudel R P K, Tsagkrasoulis D, et al. Predicting brain age with deep learning from raw imaging data results in a reliable and heritable biomarker[J]. NeuroImage, 2017, 163: 115-124. DOI: 10.1016/j. neuroimage.2017.07.059.

Cole J H. Multimodality neuroimaging brain-age in UK biobank: relationship to biomedical, lifestyle, and cognitive factors[J]. Neurobiol Aging, 2020, 92: 34-42. DOI: 10.1016/j.neurobiolaging.2020.03.014.

Cruz-jentoft A J, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(1): 16-31. DOI: 10.1093/ageing/afy169.

Urooj B, Ko Y, Na S, et al. Implementation of fully automated ai-integrated system for body composition assessment on computed tomography for opportunistic sarcopenia screening: multicenter prospective study[J/OL]. JMIR Form Res, 2025, 9: e69940. https://doi.org/ 10.2196/69940.

Ahadi S, Wilson K A, Babenko B, et al. Longitudinal fundus imaging and its genome-wide association analysis provide evidence for a human retinal aging clock[J/OL]. eLife, 2023, 12: e82364. https://doi.org/10.7554/eLife.82364.

Park S H, Jin J H, Kim J, et al. Wearable device derived electrocardiographic age and its association with atrial fibrillation[J]. NPJ Digit Med, 2026, 9(1): 157. DOI: 10.1038/s41746-026-02344-8.

Wong F, Omori S, Donghia N M, et al. Discovering small-molecule senolytics with deep neural networks[J]. Nat Aging, 2023, 3(6): 734-750. DOI: 10.1038/s43587-023-00415-z.


Refbacks

  • There are currently no refbacks.